Event
Chris Collins insider-trading case
Case over trades in Innate Immunotherapeutics shares after a failed drug trial: a guilty plea in 2019, a prison sentence in 2020, and a pardon in December 2020.
- Dates
- 22 Jun 2017 – 22 Dec 2020
Connections 4
interventions
- Donald Trump 22 Dec 2020 pardoned Chris Collins Scholarship & press 1
involved
- Chris Collins pleaded guilty in 2019; sentenced in 2020 Primary record 2
- Innate Immunotherapeutics the company whose failed drug trial was the inside information Primary record 3
- U.S. Department of Justice prosecuted through the U.S. Attorney’s Office for the Southern District of New York Primary record 3
Timeline 2 dates
- 22 Jun 2017 – 22 Dec 2020 Chris Collins insider-trading case
- 22 Dec 2020 Donald Trump intervened in Chris Collins insider-trading case
Proof 3 sources
-
A look at pardons, clemency in waning weeks of Trump tenure, Associated Press, 23 Dec 2020.
Scholarship & press
On Tuesday, Dec. 22, 2020, President Donald Trump pardoned 15 people, including Collins.
-
Former Congressman Christopher Collins Sentenced For Insider Trading Scheme And Lying To Federal Law Enforcement Agents (press release), U.S. Department of Justice, 17 Jan 2020.
Primary record
Archived copy
was sentenced to 26 months in prison today by U.S. District Judge Vernon S. Broderick for participating in a scheme to commit insider trading and for making false statements to federal law enforcement agents
-
Congressman Christopher Collins Pleads Guilty To Insider Trading Scheme And Lying To Federal Law Enforcement Agents (press release), U.S. Department of Justice, 1 Oct 2019.
Primary record
Archived copy
MIS416 – a multiple sclerosis drug that Innate was developing – had failed a critical drug trial
Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today that CHRISTOPHER COLLINS
Page history 1 change
- Add 55 stories, each checked against its sources96e92fe6
Something wrong or missing? Tell us, with a source, or edit this page.